Relievant Medsystems Secures $36 Million for INTRACEPT

Relievant Medsystems secured US $36MM in equity financing. Proceeds will support clinical studies, portfolio expansion and commercialization, including strategic initiatives with Medicare contractors and third-party private payors.

Relievant has developed INTRACEPT® Intraosseous Nerve Ablation System to treat chronic low back pain. The system...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us